Moldovan Drug Regulator Gives Conditional Use Approval To Sputnik V, Pfizer, AstraZeneca

Moldovan Drug Regulator Gives Conditional Use Approval to Sputnik V, Pfizer, AstraZeneca

The Moldovan drug regulator on Friday granted a one-year conditional authorization to three COVID-19 vaccines Sputnik V, Pfizer, AstraZeneca

CHISINAU (Pakistan Point News / Sputnik - 26th February, 2021) The Moldovan drug regulator on Friday granted a one-year conditional authorization to three COVID-19 vaccines Sputnik V, Pfizer, AstraZeneca.

The Medicines and Medical Devices Agency said in a statement that the approval was given on condition that drugmakers submit post-authorization safety and efficacy studies.

"[The agency's medicines committee] decided to conditionally approve the vaccines on the World Health Organization's Emergency Use Listing: Pfizer/BioNTech and AstraZeneca, and also Sputnik V," it said.

Earlier in the day, Former Moldovan President Igor Dodon became the first to announce the registration of Russia's Sputnik V shot. The Russian Direct Investment Fund said Moldova was the 38th country to approve the vaccine.